Intraoperative Blood Flow Measurements and Liver Allograft Function: Preliminary Results

• Published in: Transplantation proceedings 2006, Vol.38 (1), p.234-236
• Main Authors: Gontarczyk, G.W., Łągiewska, B., Pacholczyk, M., Trzebicki, J., Jureczko, L., Kołacz, M., Kosieradzki, M., Adadyński, L., Wasiak, D., Rowiński, W.
• Format: Article
• Language: English
• Subjects: Bile - secretion; Biological and medical sciences; Blood Flow Velocity; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Graft Survival - physiology; Hemodynamics; Hepatic Artery - physiopathology; Humans; Intraoperative Period; Liver Function Tests; Liver Transplantation - physiology; Medical sciences; Portal Vein - physiopathology; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Tissue, organ and graft immunology; Transplantation, Homologous
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2005.12.086

Our previous studies showed a correlation of intraoperative renal allograft blood flow and immediate functions. A similar relation is not well established for liver transplantation. The aim of this study was to assess the relation between hepatic blood flow on revascularization and immediate liver graft function (IF). Studies evaluating arterial and portal flow in newly transplanted livers were started in May 2004. Total hepatic artery and portal vein blood flow were assessed in 15 liver transplant recipients. Parenchymal flow was also recorded. Measurements were taken at 30 and 120 minutes after simultaneous arterial/portal reperfusion. Flow results were correlated with IF. Mean arterial blood flow (ABF) was 16.3 mL/min/100 g in both measurements. Portal flow was reduced from 168 to 127 mL/min/100 g from the first to the second measurement. Mean parenchymal flow (PF) did not alter over time (29.1 and 30.4 mL/min/100 g, respectively). Among recorded flow results we observed a significant correlation between PF with IF measured as: bile volume (R = 0.36 to 0.62; P < .05), serum AST (R = −0.4 to −0.68; P < .05), and ALT level (R = −0.2 to −0.71; P < .05), bilirubin level as well as INR (R = −0.39 to −0.61; P < .05) assayed daily for 14 days. Similar observations were made between ABF and INR, hiatal parenchymal flow, and ALT as well as INR. These preliminary results suggest hepatic blood flow may be a reliable predictor of graft viability and function. Of the variables measured, portal blood flow seems to be the most valuable indicator of liver function.